Ensure cross-functional alignment and harmonization of strategy with operational activities across commercial and other functions
Organize and interpret incoming data and discuss findings of relevant strategic analyses with senio
Requirements
The person in this role will have significant impact on BridgeBio and our ability to serve patients at scale.
The Chief of Staff should be:
Patient-focused
A clear and structured communicator who distills complexity into concise insights and recommendations
Comfortable operating in ambiguity and able to create clarity where none exists
Influential without formal authority, able to align senior stakeholders and drive follow-through
Detail-oriented but never lose sight of enterprise-level priorities
Biased toward action, with a strong sense of ownership and accountability
Resilient and adaptable, able to shift gears quickly as priorities evolve
Benefits
Flexible schedule
Additional Information
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a "moneyball for biotech" approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a "moneyball for biotech" approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
BridgeBio is a commercial stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with three approved drugs and three additional positive Phase 3 results, making the company one of the most productive R&D engines in the industry's history.
To learn more about our story and company culture, visit us at https://bridgebio.com